chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Immediate post-injection reaction, Pain, Pain in extremity
Clinical narrative: shoulder pain started right after administration and has persisted. pt just reported to pharmacy on 2/15/22 because the pain is still an issue. hasn't seen a dr yet but is planning on it now that he has insurance.  has used otc ibuprofen and a thc cream to help manage pain.  pain is in back of shoulder area, upper arm and does travel to elbow.  worsened by movement
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ageusia, Asthenia, COVID-19, Chest X-ray abnormal, Chills
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 12/29/2020.  76 y/o with PMHx of GERD, Prostate CA, DM, HTN, CAD s/p stents, Myasthenia gravis presents to ED with c/o Generalized weakness, body aches, fever, chills, dizziness, Loss of taste.  Pt states originally tested positive for Covid on 2/3/2022 but symptoms have progressively worsened to the point of having a difficult time caring for himself.   Pt febrile, Room air sat 94% and CXR shows mild Left sided PNA.  Pt treated with IV and po antibiotics.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Loss of personal independence in daily activities, Pain, Pneumonia, Pyrexia
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 12/29/2020.  76 y/o with PMHx of GERD, Prostate CA, DM, HTN, CAD s/p stents, Myasthenia gravis presents to ED with c/o Generalized weakness, body aches, fever, chills, dizziness, Loss of taste.  Pt states originally tested positive for Covid on 2/3/2022 but symptoms have progressively worsened to the point of having a difficult time caring for himself.   Pt febrile, Room air sat 94% and CXR shows mild Left sided PNA.  Pt treated with IV and po antibiotics.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Covid19 breakthrough.  1st vaccine received on 12/29/2020.  76 y/o with PMHx of GERD, Prostate CA, DM, HTN, CAD s/p stents, Myasthenia gravis presents to ED with c/o Generalized weakness, body aches, fever, chills, dizziness, Loss of taste.  Pt states originally tested positive for Covid on 2/3/2022 but symptoms have progressively worsened to the point of having a difficult time caring for himself.   Pt febrile, Room air sat 94% and CXR shows mild Left sided PNA.  Pt treated with IV and po antibiotics.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Femur fracture, Nausea, Open reduction of fracture
Clinical narrative: pt brought to facility for short-term rehab post right femur fracture, ORIF; tested positive for COVID on 10/1/21 with c/o nausea; DNR; placed in isolation; found in the room by CNA with no pulse and not breathing; died in the rehab center
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pulse absent, Respiratory arrest, SARS-CoV-2 test positive
Clinical narrative: pt brought to facility for short-term rehab post right femur fracture, ORIF; tested positive for COVID on 10/1/21 with c/o nausea; DNR; placed in isolation; found in the room by CNA with no pulse and not breathing; died in the rehab center
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hyperhidrosis, Tremor, White blood cell count abnormal
Clinical narrative: severe chills shaking throughout the night Profuse sweating Headache All these lasted for 3days
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram, Blood test, Computerised tomogram head, Diplopia, Feeling abnormal
Clinical narrative: Intense headache within one hour of receiving injection. Not much relief after Tylenol or ibuprofen. Day 2 (and ongoing)  Headache and high blood pressure. Day 5 (and ongoing) Headache, high blood pressure , double vision, brain fog.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypertension, Magnetic resonance imaging, Urine analysis
Clinical narrative: Intense headache within one hour of receiving injection. Not much relief after Tylenol or ibuprofen. Day 2 (and ongoing)  Headache and high blood pressure. Day 5 (and ongoing) Headache, high blood pressure , double vision, brain fog.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: After administering the vaccine, the pharmacist realized that the beyond use date from retail location was 2/12/22.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Impaired work ability, Lethargy
Clinical narrative: I experienced a terrible headache. I was febrile with chills. I was lethargic and incapable of work. I spent over 2 days in bed with malaise, body aches, and joint pain.  I felt terrible. It took me days to recover.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pain, Pyrexia
Clinical narrative: I experienced a terrible headache. I was febrile with chills. I was lethargic and incapable of work. I spent over 2 days in bed with malaise, body aches, and joint pain.  I felt terrible. It took me days to recover.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was administered vaccine beyond the published expiration date. Per Moderna Manufacterer, re-vaccination is not required, the vaccine was determined to still maintain the activity necessary to protect against Covid-19.
Age: 29.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Breast enlargement, Menstruation irregular
Clinical narrative: Had amenorrhea since beginning oral contraceptives over 15 years ago. 2 months after being fully vaccinated, began getting extended length periods again. Also, significant increase in breast size.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio, Anion gap, Anticoagulant therapy, Aspartate aminotransferase increased
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Basophil count normal, Basophil percentage, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatinine decreased, Blood glucose normal
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea decreased, Blood urea nitrogen/creatinine ratio, Brain natriuretic peptide normal
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Carbon dioxide normal, Chest X-ray normal, Decreased activity
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Differential white blood cell count, Dyspnoea, Dyspnoea exertional, Eosinophil count normal, Eosinophil percentage decreased
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Full blood count, Globulins increased, Glomerular filtration rate normal, Granulocyte percentage
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Haematocrit decreased, Haemoglobin decreased, Hypoxia, Illness, Immature granulocyte count
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunodeficiency, Lymphocyte count, Lymphocyte percentage, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Mean cell volume increased, Mean platelet volume normal, Metabolic function test, Monocyte count, Monocyte percentage
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Neutrophil count, Neutrophil percentage, Pneumonia viral, Protein total normal, Red blood cell count decreased
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Red blood cell nucleated morphology, Red cell distribution width increased, Respiratory tract congestion, Troponin normal, White blood cell count normal
Clinical narrative: 2/9/22 66-year-old male with history of congestive heart failure, hypertension, hyperlipidemia, essential thrombocythemia, CVA presented to the emergency department with shortness of breath.  Diagnosed with coronavirus most week ago, no nausea or vomiting, no diarrhea.  No abdominal pain.  No chest pain.  Patient is on chronic Xarelto for history of stroke.  Denies any complaints. Onset: 6 days, Timing: Intermittent, Location: Chest Quality: Shortness of breath, Radiation: None, Severity: Moderate, worsened by: Exertion, Relieved by: Rest, Associated symptoms: None, Review of Systems, Constitutional: Positive for activity change and fatigue. Negative for chills and fever. HENT: Negative for congestion and sore throat. Eyes: Negative for pain and discharge. Respiratory: Positive for shortness of breath. Negative for cough.Cardiovascular: Negative for chest pain, palpitations and leg swelling. Gastrointestinal: Negative for abdominal pain, nausea and vomiting. Genitourinary: Negative for dysuria, frequency and urgency. Musculoskeletal: Negative for back pain and myalgias. Skin: Negative for color change and rash. Neurological: Negative for light-headedness and headaches. 2/10/22  Discharge summary: Patient is a 66-year-old male who presents the hospital with complaints of shortness of breath.  He was diagnosed with COVID-19 6 days prior to admission and did feel weak and congested, however he began having dyspnea with exertion just prior to admission.  He went to the ICC where he was found to have O2 saturations in the mid 80s on room air.  He was placed on oxygen and sent to the ER for further evaluation where he was admitted for treatment of hypoxia related to COVID-19 viral pneumonia.  He was started on IV steroids and Remdesivir and had significant improvement in his symptoms over the last 24 hours.  He was able to ambulate without any significant DOE but will require oxygen temporarily on discharge.  This will be arranged for the patient and I will also discharge him on a course of oral Decadron.  The patient will be discharged home with referral to the virtual hospital as well.  He should also follow-up with PCP in 1 week.  He is stable for discharge at this time and anticipate he will likely need O2 for the next 1 to 2 weeks at most.  He is vaccinated and received a booster dose as well, although he is immunocompromised and therefore likely had a slightly worse course of illness due to this reason.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Gait disturbance, Hypoaesthesia, Immunodeficiency, Laboratory test abnormal
Clinical narrative: Numbness with right foot and toes, painful and had to walk on her heels, chest pressure, and had idiopathic fevers. rash on her arm.  Saw Allergist on 03/17/2021 for these problems. Dr's won't allow her to get the booster as they had to put her on Prednisone for 3 days and 1 day after as well.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rash
Clinical narrative: Numbness with right foot and toes, painful and had to walk on her heels, chest pressure, and had idiopathic fevers. rash on her arm.  Saw Allergist on 03/17/2021 for these problems. Dr's won't allow her to get the booster as they had to put her on Prednisone for 3 days and 1 day after as well.
Age: 4.0
Sex: F
Vaccine: PPV
Symptoms: Medication error, No adverse event
Clinical narrative: Med error. No adverse event
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: After administering Covid Vaccine, the pharmacist realized that the beyond use date given from the Retail location was 2/12/22.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arterial rupture, Blood test abnormal, Computerised tomogram, Electrocardiogram, Internal haemorrhage
Clinical narrative: After the vaccination he threw up and had sore arm and at night the whole body was aching. A couple of days later he went to the hospital and the doctors said his arteries are ruptured and they ran a couple of tests but couldn't find anything wrong. The blood pressure was really bad and they kept him 3 days and two days later he dropped again and we went to the emergency again and they ran a couple of tests and found out he was bleeding internal his blood cell count was really low and that's when they did a treatment on him.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Vomiting
Clinical narrative: After the vaccination he threw up and had sore arm and at night the whole body was aching. A couple of days later he went to the hospital and the doctors said his arteries are ruptured and they ran a couple of tests but couldn't find anything wrong. The blood pressure was really bad and they kept him 3 days and two days later he dropped again and we went to the emergency again and they ran a couple of tests and found out he was bleeding internal his blood cell count was really low and that's when they did a treatment on him.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest discomfort, Pain, Rash erythematous, Rash pruritic
Clinical narrative: 1/9 It started with upper arm and shin rash that was red, raised, and itchy.  At that point called my PCP and was advised over the phone to wait it out. Advised to keep hydrated and started using hydrocortisone cream. Opted to get a CoVid test because of the rash, chest congestion, and body ache.  Rash lasted for 5-6 days and has not returned. The other symptoms subsided as well. No additional issues and I am fully recovered.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 1/9 It started with upper arm and shin rash that was red, raised, and itchy.  At that point called my PCP and was advised over the phone to wait it out. Advised to keep hydrated and started using hydrocortisone cream. Opted to get a CoVid test because of the rash, chest congestion, and body ache.  Rash lasted for 5-6 days and has not returned. The other symptoms subsided as well. No additional issues and I am fully recovered.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Pyrexia, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: Late on Feb 8th I started to get a tickle in my throat, the following day, by 8pm I had a 102 F. fever.  I took 2 at home tests and both were positive. I called my Transplant team and they scheduled Monoclonal Antibodies for the following day 2/10/22 at 2pm. My fever broke over night and all symptoms worked there way out by 2/14/22. I AM IMMUNOCOMPROMISED. I got my 4th vaccine right on the 4 month mark per Dr. guidelines. I am very certain that I caught this at the grocery store the morning of 2/7/22 when I accidentally ran into someone coughing severely in the parking lot.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Modera. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Vaccine undiluted
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: No adverse affect reported from patient. Clinic held Moderna vaccine at lower temp than recommended by Moderna. Vaccine was held at -90 to -60 degrees Celsius. Moderna deemed vaccine viable for use.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: Pateint recieved booster dose evening of 2/11 in the right delt, IM injection. 0.25 cc Moderna. The next day around 10 AM arm was very sore and her hand and fingers were numb.  All fingers are numb, by 2/14 most of hand numbness has resolved. the right thumb and 2nd fingers are still numb on 2/15
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Lymphadenopathy
Clinical narrative: Swollen lymph nodes throughout neck area and around ear on the left side as well as a bright red left ear lobe (injection was given on the left arm). All of these symptoms last approx 5-6 days.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Pharmacist working Monday 2/14 Noticed that the beyond use date for current batch of vaccines was 2/12/22. This vaccine should not have been used in the patient.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Injection site swelling, Injection site warmth
Clinical narrative: The day after the shot, the arm developed a large raised, red, hot, painful welt, about the size of a plum, a couple inches below the injection site.  The welt remained painful for a week and gradually resolved on its own.  Patient (self) is unsure whether this indicates a future dose of this vaccine could be poorly tolerated.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: The day after the shot, the arm developed a large raised, red, hot, painful welt, about the size of a plum, a couple inches below the injection site.  The welt remained painful for a week and gradually resolved on its own.  Patient (self) is unsure whether this indicates a future dose of this vaccine could be poorly tolerated.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Echocardiogram abnormal, Myocarditis, Troponin increased
Clinical narrative: chest pain, myocarditis with troponin elevation
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chest pain, Pulmonary embolism
Clinical narrative: 74y/o Caucasian woman, PMHx of Morbid Obesity, HTN, Hyperlipidemia, Hypothyroid, COPD who contracted COVID-19 in August 2021. She was hospitalized, treated and discharged home. Several months later, she received her 1st dose of Pfizer COVID Vaccine on 2/14/2022. A few hours later, developed epigastric and lower chest pain that lasted through the night. She came to Hospital Emergency Department on 2/15/2022. She was found to have Bilateral Pulmonary Emboli and was admitted to the hospital for further care and treatment.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Chest pain, Chills, Dermatitis contact, Dizziness
Clinical narrative: About 10 mins after the injection, I started to feel a dull ache in my throat area (like in the glands around the throat, as well as in my chest area. I felt light headed. A couple of minutes later the ache worsened and nurses took me to check my vitals. O2 was 97% aprox. and my pressure was a bit elevated but not extreme. I had knowledge of a very mild reaction to the first dose, so I had Benadryl with me. I took 1 Benadryl and waited in the waiting room for another 20mins to be sure. I left after the 20mins with the same level of pain in my throat, lightheadedness was gone. That night I had a fever of 100.02F aprox, about a 5 (scale 1(no pain or discomfort) to 10 (dying, ER neded)) in scale of body aches, chills, vaccine area in arm was extremely (7) painful. My throat glands got swollen, visibly and to the touch, painful to swallow. I felt like I had a very bad (7 in scale) flu.  Pain and throat glands swollen for about 2 days after vax. Flu like aches one day and fever was only the night of the vax.  AFTER VAX INFO Since September 2021 I've been experiencing rare allergic reactions to foods and dry detergent. I'm seeking an allergist to asses.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Food allergy, Influenza like illness, Injection site pain, Lymphadenopathy, Odynophagia
Clinical narrative: About 10 mins after the injection, I started to feel a dull ache in my throat area (like in the glands around the throat, as well as in my chest area. I felt light headed. A couple of minutes later the ache worsened and nurses took me to check my vitals. O2 was 97% aprox. and my pressure was a bit elevated but not extreme. I had knowledge of a very mild reaction to the first dose, so I had Benadryl with me. I took 1 Benadryl and waited in the waiting room for another 20mins to be sure. I left after the 20mins with the same level of pain in my throat, lightheadedness was gone. That night I had a fever of 100.02F aprox, about a 5 (scale 1(no pain or discomfort) to 10 (dying, ER neded)) in scale of body aches, chills, vaccine area in arm was extremely (7) painful. My throat glands got swollen, visibly and to the touch, painful to swallow. I felt like I had a very bad (7 in scale) flu.  Pain and throat glands swollen for about 2 days after vax. Flu like aches one day and fever was only the night of the vax.  AFTER VAX INFO Since September 2021 I've been experiencing rare allergic reactions to foods and dry detergent. I'm seeking an allergist to asses.